Valuation: MiniMed Group, Inc.

Market Cap 5.66B 4.89B 4.58B 4.17B 7.85B 541B 7.96B 53.73B 21.05B 271B 21.25B 20.79B 902B P/E 2027 *
32.2x
P/E 2028 * 31.7x
Enterprise Value 5.27B 4.55B 4.27B 3.88B 7.3B 504B 7.41B 50B 19.59B 252B 19.77B 19.34B 839B EV / Sales 2027 *
1.54x
EV / Sales 2028 * 1.36x
Free-Float
9.28%
Yield 2027 *
-
Yield 2028 * -
1 day-4.04%
1 week-0.82%
Current month+7.15%
1 month+14.24%
3 months+77.76%
1 week 19.1
Extreme 19.1001
20.88
1 month 15.96
Extreme 15.96
20.88
Current year 10.65
Extreme 10.65
20.88
1 year 10.65
Extreme 10.65
20.88
3 years 10.65
Extreme 10.65
20.88
5 years 10.65
Extreme 10.65
20.88
10 years 10.65
Extreme 10.65
20.88
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-3.92%-0.82% - - 5.66B
+0.04%+0.35%+28.11%+28.29% 12.88B
-0.17%+0.21%+17.16%+29.67% 6.88B
+5.91%+11.22%+55.30%+51.32% 6.46B
-1.23%+3.18%-27.67%+50.65% 4.56B
-0.64%-3.95%-26.40%-23.93% 3.91B
+3.36%+1.21%+44.91%-44.38% 1.97B
-1.98%-0.92%+58.37%-6.27% 1.71B
-0.77%-10.86%-34.06%+130.80% 1.55B
-1.27%+1.35%-28.24%-41.30% 1.34B
Average -0.11%+0.08%+9.72%+19.43% 4.69B
Weighted average by Cap. +0.09%+0.96%+17.10%+26.33%

Financials

2027 *2028 *
Net sales 3.42B 2.95B 2.77B 2.52B 4.75B 327B 4.81B 32.49B 12.73B 164B 12.85B 12.57B 545B 3.71B 3.2B 3B 2.74B 5.15B 355B 5.22B 35.22B 13.8B 178B 13.93B 13.63B 591B
Net income 175M 151M 142M 129M 243M 16.74B 246M 1.66B 651M 8.39B 657M 643M 27.89B 207M 179M 168M 153M 288M 19.82B 292M 1.97B 771M 9.93B 778M 761M 33.03B
Net Debt -393M -339M -318M -290M -545M -37.54B -552M -3.73B -1.46B -18.81B -1.47B -1.44B -62.57B -601M -519M -487M -443M -833M -57.43B -845M -5.7B -2.23B -28.77B -2.26B -2.21B -95.72B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-08-17 US$19.36 -3.95% 554,217
26-08-14 US$20.15 +0.65% 1,069,158
26-08-13 US$20.02 -3.29% 1,092,078
26-08-12 US$20.70 +4.65% 1,311,988
26-08-11 US$19.78 +1.44% 779,580
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
20.15USD
Average target price
20.83USD
Spread / Average Target
+3.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock